VEGFA and neoplasm: Anti-angiogenic drugs target vascular endothelial growth factor (VEGF) and its receptor pathway to reduce angiogenesis, regulate the tumour microenvironment, and thus exert anti-tumour effects, and combined with immunotherapy drugs can have a synergistic anti-tumour effect.